Lichen International Limited
LICN
$3.53
$0.3711.71%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.63% | 13.63% | 34.99% | 34.99% | -1.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.63% | 13.63% | 34.99% | 34.99% | -1.39% |
| Cost of Revenue | 16.94% | 16.94% | 18.74% | 18.74% | 6.13% |
| Gross Profit | 11.57% | 11.57% | 48.06% | 48.06% | -5.54% |
| SG&A Expenses | 32.78% | 32.78% | 3.59% | 3.59% | 50.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.39% | 25.39% | 12.91% | 12.91% | 25.94% |
| Operating Income | -40.32% | -40.32% | 92.81% | 92.81% | -50.56% |
| Income Before Tax | -17.93% | -17.93% | 96.69% | 96.69% | -63.78% |
| Income Tax Expenses | 25.63% | 25.63% | 87.33% | 87.33% | -50.68% |
| Earnings from Continuing Operations | -43.48% | -43.48% | 100.20% | 100.20% | -68.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.48% | -43.48% | 100.20% | 100.20% | -68.67% |
| EBIT | -40.32% | -40.32% | 92.81% | 92.81% | -50.56% |
| EBITDA | -37.63% | -37.63% | 78.88% | 78.88% | -43.48% |
| EPS Basic | -51.32% | -51.32% | 69.94% | 69.94% | -72.50% |
| Normalized Basic EPS | -29.01% | -29.01% | 66.97% | 66.97% | -68.22% |
| EPS Diluted | -51.32% | -51.32% | 69.94% | 69.94% | -72.50% |
| Normalized Diluted EPS | -29.01% | -29.01% | 66.97% | 66.97% | -68.22% |
| Average Basic Shares Outstanding | 15.98% | 15.98% | 17.81% | 17.81% | 13.96% |
| Average Diluted Shares Outstanding | 15.98% | 15.98% | 17.81% | 17.81% | 13.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |